Ledger.Open graph →
SEC Form D · filed November 16, 2020

Cyrano Therapeutics, Inc

Offering
$12.8M
Sold
$4.1M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Gerry Brunk · Woodridge, ILDirectorTakahide Koda · Seattle, WADirectorRichard Geoffrion · Washington, Washington, D.C.Exec · DirectorGerry Brunk · Woodridge, ILDirectorRobert Henkin · Washington, Washington, D.C.DirectorRichard Geoffrion · Washington, Washington, D.C.Exec · DirectorGerry Brunk · Toronto, Ontario, CanadaDirectorTakahide Koda · Seattle, WADirectorRobert Henkin · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗